HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jeremie Vitte Selected Research
Jeremie Vitte Research Topics
Disease
8
Neoplasms (Cancer)
11/2023 - 07/2013
5
Neurilemmoma (Schwannoma)
02/2024 - 07/2013
3
Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2019 - 07/2013
3
Carcinogenesis
11/2016 - 07/2013
2
Acoustic Neuroma (Acoustic Neurinoma)
02/2024 - 04/2014
2
Schwannomatosis
11/2023 - 03/2013
2
Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2023 - 01/2018
1
Neurofibromatoses (Neurofibromatosis)
11/2023
1
Rare Diseases (Rare Disease)
11/2023
1
Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1
Inflammation (Inflammations)
11/2016
1
Hepatomegaly
11/2016
1
Meningioma (Meningiomas)
07/2013
Drug/Important Bio-Agent (IBA)
4
Neurofibromin 2 (Merlin)
IBA
01/2023 - 04/2014
3
Proteins (Proteins, Gene)
FDA Link
11/2023 - 07/2013
2
Mechanistic Target of Rapamycin Complex 1
IBA
02/2024 - 04/2014
2
Biomarkers (Surrogate Marker)
IBA
02/2024 - 01/2023
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2019 - 07/2013
1
Everolimus
FDA Link
02/2024
1
Ligands
IBA
01/2023
1
DNA (Deoxyribonucleic Acid)
IBA
01/2019
1
trametinib
IBA
01/2019
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2019
1
Neurofibromin 1 (Neurofibromin)
IBA
01/2018
1
Cyclins
IBA
11/2016
1
Cytokines
IBA
11/2016
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2016
1
Sirolimus (Rapamycin)
FDA Link
04/2014
1
TOR Serine-Threonine Kinases
IBA
04/2014
1
pochoxime A
IBA
07/2013
Therapy/Procedure
3
Therapeutics
11/2023 - 07/2013
1
Drug Therapy (Chemotherapy)
03/2013